In vivo, AEVs inhibited tumor growth by shifting macrophage polarization from the M2-like to the M1-like phenotype, and synergistically enhancing the recruitment of CD8+ and CD4+ T cells into the tumor microenvironment. This evidence concerns the gene CD4 and neoplasm.